{
    "info": {
        "nct_id": "NCT05488626",
        "official_title": "Daily Adaptive vs Non-Adaptive External Beam Radiation Therapy With Concurrent Chemotherapy for Locally Advanced Non-Small Cell Lung Cancer: A Prospective Randomized Trial of an Individualized Approach for Toxicity Reduction (ARTIA-Lung)",
        "inclusion_criteria": "1. Provision of signed and dated informed consent form.\n2. Histologically confirmed NSCLC\n3. Clinical stage IIIA-IIIB (AJCC v8) disease who are either:\n\n   1. Patients classified as non-operable by the treatment team\n   2. Patients who refuse surgery\n4. Clinical stage IIIC due to contralateral mediastinal lymph node involvement only (e.g., no contralateral hilar or any supraclavicular/cervical lymph node metastases). Mediastinal stations 2R and 4R are considered contralateral for patients whose primary tumor is within the left lung. Mediastinal stations 2L, 4L, 5, and 6 are considered contralateral for patients whose primary tumor is in the right lung.\n5. Completed evaluation for metastatic disease with no distant metastases identified. Evaluation must include the following:\n\n   1. History and physical examination within 30 days prior to enrollment.\n   2. Whole body FDG PET-CT for staging within 60 days prior to enrollment\n   3. Brain MRI or contrast enhanced CT within 60 days prior to enrollment.\n6. ECOG performance status 0-2 and deemed clinically fit for chemoradiotherapy.\n7. Age ≥18 years (or at least the local age of consent)\n8. Patients must have normal organ and marrow function.\n9. Serum creatinine ≤1.5 mg/dL within 60 days prior to enrollment.\n10. Measurable disease must be present.\n11. Negative urine or serum pregnancy test within 14 days prior to enrollment for women of childbearing potential.\nHealthy volunteers allowed\nMust have minimum age of 18 Years",
        "exclusion_criteria": "1. Contralateral hilar or any supraclavicular/cervical lymph nodes.\n2. Baseline grade ≥3 dyspnea, or cough, or dysphagia.\n3. Prior invasive non-skin malignancy unless disease free for a minimum of 3 years.\n4. History of prior RT to the thorax.\n5. Severe imaging artifact that, in the view of the local investigator, would preclude accurate identification of the thoracic anatomy and tumor targets on the cone beam CT (e.g., artifact created implanted cardiac device in proximity to the targets).\n6. Evidence of malignant pleural effusion, defined as either FDG PET avidity within effusion fluid or presence of malignant cells identified by cytology of thoracentesis fluid.\n7. Severe active chronic obstructive pulmonary disease or respiratory illness other than NSCLC precluding study therapy.\n8. Hospitalization for chronic obstructive pulmonary disease or respiratory illness other than NSCLC within 1 year prior to study enrollment.\n9. Women of childbearing potential and sexually active women not willing or able to use contraception.",
        "miscellaneous_criteria": ""
    },
    "inclusion_lines": [
        {
            "line": "Must have minimum age of 18 Years",
            "criterions": [
                {
                    "exact_snippets": "minimum age of 18 Years",
                    "criterion": "age",
                    "requirements": [
                        {
                            "requirement_type": "minimum",
                            "expected_value": {
                                "operator": ">=",
                                "value": 18,
                                "unit": "years"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "5. Completed evaluation for metastatic disease with no distant metastases identified. Evaluation must include the following:",
            "criterions": [
                {
                    "exact_snippets": "Completed evaluation for metastatic disease",
                    "criterion": "evaluation for metastatic disease",
                    "requirements": [
                        {
                            "requirement_type": "completion",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "no distant metastases identified",
                    "criterion": "distant metastases",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": false
                        }
                    ]
                }
            ]
        },
        {
            "line": "11. Negative urine or serum pregnancy test within 14 days prior to enrollment for women of childbearing potential.",
            "criterions": [
                {
                    "exact_snippets": "Negative urine or serum pregnancy test within 14 days prior to enrollment for women of childbearing potential.",
                    "criterion": "pregnancy test result",
                    "requirements": [
                        {
                            "requirement_type": "test type",
                            "expected_value": [
                                "urine",
                                "serum"
                            ]
                        },
                        {
                            "requirement_type": "result",
                            "expected_value": "negative"
                        },
                        {
                            "requirement_type": "time window",
                            "expected_value": {
                                "operator": "<=",
                                "value": 14,
                                "unit": "days prior to enrollment"
                            }
                        },
                        {
                            "requirement_type": "applicability",
                            "expected_value": "women of childbearing potential"
                        }
                    ]
                }
            ]
        },
        {
            "line": "1. History and physical examination within 30 days prior to enrollment.",
            "criterions": [
                {
                    "exact_snippets": "History and physical examination within 30 days prior to enrollment.",
                    "criterion": "history and physical examination",
                    "requirements": [
                        {
                            "requirement_type": "timing",
                            "expected_value": {
                                "operator": "<=",
                                "value": 30,
                                "unit": "days prior to enrollment"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "6. ECOG performance status 0-2 and deemed clinically fit for chemoradiotherapy.",
            "criterions": [
                {
                    "exact_snippets": "ECOG performance status 0-2",
                    "criterion": "ECOG performance status",
                    "requirements": [
                        {
                            "requirement_type": "value",
                            "expected_value": {
                                "comparisons": [
                                    {
                                        "operator": ">=",
                                        "value": 0,
                                        "unit": "N/A"
                                    },
                                    {
                                        "operator": "<=",
                                        "value": 2,
                                        "unit": "N/A"
                                    }
                                ]
                            }
                        }
                    ]
                },
                {
                    "exact_snippets": "deemed clinically fit for chemoradiotherapy",
                    "criterion": "clinical fitness for chemoradiotherapy",
                    "requirements": [
                        {
                            "requirement_type": "fitness",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "4. Clinical stage IIIC due to contralateral mediastinal lymph node involvement only (e.g., no contralateral hilar or any supraclavicular/cervical lymph node metastases). Mediastinal stations 2R and 4R are considered contralateral for patients whose primary tumor is within the left lung. Mediastinal stations 2L, 4L, 5, and 6 are considered contralateral for patients whose primary tumor is in the right lung.",
            "criterions": [
                {
                    "exact_snippets": "Clinical stage IIIC due to contralateral mediastinal lymph node involvement only (e.g., no contralateral hilar or any supraclavicular/cervical lymph node metastases)",
                    "criterion": "clinical stage",
                    "requirements": [
                        {
                            "requirement_type": "stage",
                            "expected_value": "IIIC"
                        }
                    ]
                },
                {
                    "exact_snippets": "contralateral mediastinal lymph node involvement only (e.g., no contralateral hilar or any supraclavicular/cervical lymph node metastases)",
                    "criterion": "contralateral mediastinal lymph node involvement",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "no contralateral hilar or any supraclavicular/cervical lymph node metastases",
                    "criterion": "contralateral hilar lymph node metastases",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": false
                        }
                    ]
                },
                {
                    "exact_snippets": "no contralateral hilar or any supraclavicular/cervical lymph node metastases",
                    "criterion": "supraclavicular/cervical lymph node metastases",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": false
                        }
                    ]
                },
                {
                    "exact_snippets": "Mediastinal stations 2R and 4R are considered contralateral for patients whose primary tumor is within the left lung",
                    "criterion": "mediastinal lymph node stations 2R and 4R",
                    "requirements": [
                        {
                            "requirement_type": "contralateral status",
                            "expected_value": "for left lung primary tumor"
                        }
                    ]
                },
                {
                    "exact_snippets": "Mediastinal stations 2L, 4L, 5, and 6 are considered contralateral for patients whose primary tumor is in the right lung",
                    "criterion": "mediastinal lymph node stations 2L, 4L, 5, and 6",
                    "requirements": [
                        {
                            "requirement_type": "contralateral status",
                            "expected_value": "for right lung primary tumor"
                        }
                    ]
                }
            ]
        },
        {
            "line": "Healthy volunteers allowed",
            "criterions": [
                {
                    "exact_snippets": "Healthy volunteers allowed",
                    "criterion": "healthy volunteer status",
                    "requirements": [
                        {
                            "requirement_type": "eligibility",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "10. Measurable disease must be present.",
            "criterions": [
                {
                    "exact_snippets": "Measurable disease must be present.",
                    "criterion": "measurable disease",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "2. Whole body FDG PET-CT for staging within 60 days prior to enrollment",
            "criterions": [
                {
                    "exact_snippets": "Whole body FDG PET-CT for staging",
                    "criterion": "whole body FDG PET-CT scan",
                    "requirements": [
                        {
                            "requirement_type": "purpose",
                            "expected_value": "staging"
                        }
                    ]
                },
                {
                    "exact_snippets": "within 60 days prior to enrollment",
                    "criterion": "whole body FDG PET-CT scan",
                    "requirements": [
                        {
                            "requirement_type": "timing",
                            "expected_value": {
                                "operator": "<=",
                                "value": 60,
                                "unit": "days prior to enrollment"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "1. Patients classified as non-operable by the treatment team",
            "criterions": [
                {
                    "exact_snippets": "Patients classified as non-operable by the treatment team",
                    "criterion": "operability status",
                    "requirements": [
                        {
                            "requirement_type": "classification",
                            "expected_value": "non-operable"
                        }
                    ]
                }
            ]
        },
        {
            "line": "3. Clinical stage IIIA-IIIB (AJCC v8) disease who are either:",
            "criterions": [
                {
                    "exact_snippets": "Clinical stage IIIA-IIIB (AJCC v8) disease",
                    "criterion": "clinical stage",
                    "requirements": [
                        {
                            "requirement_type": "stage",
                            "expected_value": {
                                "comparisons": [
                                    {
                                        "operator": ">=",
                                        "value": 3,
                                        "unit": "A"
                                    },
                                    {
                                        "operator": "<=",
                                        "value": 3,
                                        "unit": "B"
                                    }
                                ]
                            }
                        },
                        {
                            "requirement_type": "staging_system",
                            "expected_value": "AJCC v8"
                        }
                    ]
                }
            ]
        },
        {
            "line": "3. Brain MRI or contrast enhanced CT within 60 days prior to enrollment.",
            "criterions": [
                {
                    "exact_snippets": "Brain MRI or contrast enhanced CT within 60 days prior to enrollment.",
                    "criterion": "brain MRI or contrast enhanced CT",
                    "requirements": [
                        {
                            "requirement_type": "completion_timeframe",
                            "expected_value": {
                                "operator": "<=",
                                "value": 60,
                                "unit": "days prior to enrollment"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "9. Serum creatinine ≤1.5 mg/dL within 60 days prior to enrollment.",
            "criterions": [
                {
                    "exact_snippets": "Serum creatinine ≤1.5 mg/dL within 60 days prior to enrollment.",
                    "criterion": "serum creatinine",
                    "requirements": [
                        {
                            "requirement_type": "quantity",
                            "expected_value": {
                                "operator": "<=",
                                "value": 1.5,
                                "unit": "mg/dL"
                            }
                        },
                        {
                            "requirement_type": "measurement_timeframe",
                            "expected_value": "within 60 days prior to enrollment"
                        }
                    ]
                }
            ]
        },
        {
            "line": "2. Histologically confirmed NSCLC",
            "criterions": [
                {
                    "exact_snippets": "Histologically confirmed NSCLC",
                    "criterion": "NSCLC (non-small cell lung cancer)",
                    "requirements": [
                        {
                            "requirement_type": "diagnosis",
                            "expected_value": "histologically confirmed"
                        }
                    ]
                }
            ]
        },
        {
            "line": "2. Patients who refuse surgery",
            "criterions": [
                {
                    "exact_snippets": "Patients who refuse surgery",
                    "criterion": "surgery",
                    "requirements": [
                        {
                            "requirement_type": "refusal",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "8. Patients must have normal organ and marrow function.",
            "criterions": [
                {
                    "exact_snippets": "normal organ and marrow function",
                    "criterion": "organ function",
                    "requirements": [
                        {
                            "requirement_type": "status",
                            "expected_value": "normal"
                        }
                    ]
                },
                {
                    "exact_snippets": "normal organ and marrow function",
                    "criterion": "marrow function",
                    "requirements": [
                        {
                            "requirement_type": "status",
                            "expected_value": "normal"
                        }
                    ]
                }
            ]
        },
        {
            "line": "7. Age ≥18 years (or at least the local age of consent)",
            "criterions": [
                {
                    "exact_snippets": "Age ≥18 years (or at least the local age of consent)",
                    "criterion": "age",
                    "requirements": [
                        {
                            "requirement_type": "minimum age",
                            "expected_value": {
                                "comparisons": [
                                    {
                                        "operator": ">=",
                                        "value": 18,
                                        "unit": "years"
                                    }
                                ]
                            }
                        },
                        {
                            "requirement_type": "minimum age",
                            "expected_value": "at least the local age of consent"
                        }
                    ]
                }
            ]
        },
        {
            "line": "1. Provision of signed and dated informed consent form.",
            "criterions": [
                {
                    "exact_snippets": "Provision of signed and dated informed consent form",
                    "criterion": "informed consent form",
                    "requirements": [
                        {
                            "requirement_type": "signed",
                            "expected_value": true
                        },
                        {
                            "requirement_type": "dated",
                            "expected_value": true
                        },
                        {
                            "requirement_type": "provision",
                            "expected_value": true
                        }
                    ]
                }
            ]
        }
    ],
    "exclusion_lines": [
        {
            "line": "7. Severe active chronic obstructive pulmonary disease or respiratory illness other than NSCLC precluding study therapy.",
            "criterions": [
                {
                    "exact_snippets": "Severe active chronic obstructive pulmonary disease",
                    "criterion": "chronic obstructive pulmonary disease",
                    "requirements": [
                        {
                            "requirement_type": "severity",
                            "expected_value": "severe"
                        },
                        {
                            "requirement_type": "activity",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "respiratory illness other than NSCLC precluding study therapy",
                    "criterion": "respiratory illness other than NSCLC",
                    "requirements": [
                        {
                            "requirement_type": "activity",
                            "expected_value": true
                        },
                        {
                            "requirement_type": "precludes study therapy",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "8. Hospitalization for chronic obstructive pulmonary disease or respiratory illness other than NSCLC within 1 year prior to study enrollment.",
            "criterions": [
                {
                    "exact_snippets": "Hospitalization for chronic obstructive pulmonary disease ... within 1 year prior to study enrollment.",
                    "criterion": "hospitalization for chronic obstructive pulmonary disease",
                    "requirements": [
                        {
                            "requirement_type": "time frame",
                            "expected_value": {
                                "operator": "<=",
                                "value": 1,
                                "unit": "year prior to study enrollment"
                            }
                        },
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "Hospitalization for ... respiratory illness other than NSCLC within 1 year prior to study enrollment.",
                    "criterion": "hospitalization for respiratory illness other than NSCLC",
                    "requirements": [
                        {
                            "requirement_type": "time frame",
                            "expected_value": {
                                "operator": "<=",
                                "value": 1,
                                "unit": "year prior to study enrollment"
                            }
                        },
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "3. Prior invasive non-skin malignancy unless disease free for a minimum of 3 years.",
            "criterions": [
                {
                    "exact_snippets": "Prior invasive non-skin malignancy",
                    "criterion": "prior invasive non-skin malignancy",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": false
                        }
                    ]
                },
                {
                    "exact_snippets": "unless disease free for a minimum of 3 years",
                    "criterion": "disease free period after prior invasive non-skin malignancy",
                    "requirements": [
                        {
                            "requirement_type": "duration disease free",
                            "expected_value": {
                                "operator": ">=",
                                "value": 3,
                                "unit": "years"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "2. Baseline grade ≥3 dyspnea, or cough, or dysphagia.",
            "criterions": [
                {
                    "exact_snippets": "Baseline grade ≥3 dyspnea",
                    "criterion": "dyspnea",
                    "requirements": [
                        {
                            "requirement_type": "grade",
                            "expected_value": {
                                "operator": ">=",
                                "value": 3,
                                "unit": "N/A"
                            }
                        }
                    ]
                },
                {
                    "exact_snippets": "Baseline grade ≥3 ... cough",
                    "criterion": "cough",
                    "requirements": [
                        {
                            "requirement_type": "grade",
                            "expected_value": {
                                "operator": ">=",
                                "value": 3,
                                "unit": "N/A"
                            }
                        }
                    ]
                },
                {
                    "exact_snippets": "Baseline grade ≥3 ... dysphagia",
                    "criterion": "dysphagia",
                    "requirements": [
                        {
                            "requirement_type": "grade",
                            "expected_value": {
                                "operator": ">=",
                                "value": 3,
                                "unit": "N/A"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "4. History of prior RT to the thorax.",
            "criterions": [
                {
                    "exact_snippets": "History of prior RT to the thorax.",
                    "criterion": "prior radiotherapy to the thorax",
                    "requirements": [
                        {
                            "requirement_type": "history",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "9. Women of childbearing potential and sexually active women not willing or able to use contraception.",
            "criterions": [
                {
                    "exact_snippets": "Women of childbearing potential",
                    "criterion": "childbearing potential",
                    "requirements": [
                        {
                            "requirement_type": "sex",
                            "expected_value": "female"
                        },
                        {
                            "requirement_type": "childbearing potential",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "sexually active women not willing or able to use contraception",
                    "criterion": "contraception use",
                    "requirements": [
                        {
                            "requirement_type": "sex",
                            "expected_value": "female"
                        },
                        {
                            "requirement_type": "sexual activity",
                            "expected_value": true
                        },
                        {
                            "requirement_type": "willingness or ability to use contraception",
                            "expected_value": false
                        }
                    ]
                }
            ]
        },
        {
            "line": "6. Evidence of malignant pleural effusion, defined as either FDG PET avidity within effusion fluid or presence of malignant cells identified by cytology of thoracentesis fluid.",
            "criterions": [
                {
                    "exact_snippets": "Evidence of malignant pleural effusion",
                    "criterion": "malignant pleural effusion",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "FDG PET avidity within effusion fluid",
                    "criterion": "FDG PET avidity in effusion fluid",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "presence of malignant cells identified by cytology of thoracentesis fluid",
                    "criterion": "malignant cells in thoracentesis fluid cytology",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "1. Contralateral hilar or any supraclavicular/cervical lymph nodes.",
            "criterions": [
                {
                    "exact_snippets": "Contralateral hilar ... lymph nodes",
                    "criterion": "contralateral hilar lymph nodes",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "supraclavicular/cervical lymph nodes",
                    "criterion": "supraclavicular or cervical lymph nodes",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "5. Severe imaging artifact that, in the view of the local investigator, would preclude accurate identification of the thoracic anatomy and tumor targets on the cone beam CT (e.g., artifact created implanted cardiac device in proximity to the targets).",
            "criterions": [
                {
                    "exact_snippets": "Severe imaging artifact that, in the view of the local investigator, would preclude accurate identification of the thoracic anatomy and tumor targets on the cone beam CT",
                    "criterion": "imaging artifact",
                    "requirements": [
                        {
                            "requirement_type": "severity",
                            "expected_value": "severe"
                        },
                        {
                            "requirement_type": "impact on identification",
                            "expected_value": "would preclude accurate identification of the thoracic anatomy and tumor targets on the cone beam CT"
                        }
                    ]
                }
            ]
        }
    ],
    "miscellaneous_lines": [],
    "failed_inclusion": [],
    "failed_exclusion": [],
    "failed_miscellaneous": []
}